Dr .Ethan Russo, is a board-certified neurologist, psychopharmacology researcher, and the director of the Institute For Cannabis and Cannabinoid Research. He is a former Senior Medical Advisor to GW Pharmaceuticals, a biotechnology company that specializes in developing different ways of targeting the endocannabinoid system for therapeutic benefit.
He is a former Senior Medical Advisor to GW Pharmaceuticals, a biotechnologycompany that specializes in developing different ways of targeting the endocannabinoid system for therapeutic benefit.
He is currently Past-President of the International Cannabinoid Research Society, and is former Chairman of the International Association for Cannabinoid Medicines. Dr Russo is also the founder and CEO of CReDO while also being renowned as a widely published author in many scientific journals, and contributor and editor of several books
Do we really how much about the endocannabinoid system (ECS) at all and do the terpenes in cannabis matter? We ask Dr Russo just that and more in this episode. We discuss how without clinical research to support the cannabis movement we don’t have a foundation for the future of this plant medically. The cannabis prohibition greatly affected the development of this much needed research but with new evidence emerging supporting the Entourage effect we talk through what this mean for us today.
Disclaimer: The information presented in this podcast is for educational purposes only, and is not intended to replace professional medical advice. Please consult your doctor if you are in need of medical care, and before making any changes to your health routine.